
Marcus (MCS) Stock Forecast & Price Target
Marcus (MCS) Analyst Ratings
Bulls say
Marcus Corp's positive outlook is supported by a strong anticipated revenue growth of 8.2%, reaching $150 million, primarily driven by its dominant theatre segment. The estimated 26% full-year box office increase and an expected 15.8% rise in wide releases in 2025 further indicate a robust recovery in the film industry, which is likely to enhance patron engagement. Additionally, the company's year-over-year EBITDA growth of 42% and RevPAR growth of 3.6%, exceeding industry averages, underscore solid operational performance and resilience across both business segments.
Bears say
Marcus Corp faces a troubling outlook primarily due to a substantial decline in the box office performance, with April and May 2024 showing a 40% decrease from the previous year, creating challenging year-over-year comparisons for the upcoming peak summer months. Additionally, the Hotels and Resorts segment has reported year-over-year profit reductions, reflecting the impact of a conservative pricing strategy amid an unpredictable market. These factors are compounded by impairment charges on theatre properties and overall lower operating income across segments, suggesting a decline in performance consistency amid external economic pressures.
This aggregate rating is based on analysts' research of Marcus and is not a guaranteed prediction by Public.com or investment advice.
Marcus (MCS) Analyst Forecast & Price Prediction
Start investing in Marcus (MCS)
Order type
Buy in
Order amount
Est. shares
0 shares